Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Clarification Free access | 10.1172/JCI46312

PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome

Inga Ebermann, Jennifer B. Phillips, Max C. Liebau, Robert K. Koenekoop, Bernhard Schermer, Irma Lopez, Ellen Schäfer, Anne-Francoise Roux, Claudia Dafinger, Antje Bernd, Eberhart Zrenner, Mireille Claustres, Bernardo Blanco, Gudrun Nürnberg, Peter Nürnberg, Rebecca Ruland, Monte Westerfield, Thomas Benzing, and Hanno J. Bolz

Find articles by Ebermann, I. in: JCI | PubMed | Google Scholar

Find articles by Phillips, J. in: JCI | PubMed | Google Scholar

Find articles by Liebau, M. in: JCI | PubMed | Google Scholar

Find articles by Koenekoop, R. in: JCI | PubMed | Google Scholar

Find articles by Schermer, B. in: JCI | PubMed | Google Scholar

Find articles by Lopez, I. in: JCI | PubMed | Google Scholar

Find articles by Schäfer, E. in: JCI | PubMed | Google Scholar

Find articles by Roux, A. in: JCI | PubMed | Google Scholar

Find articles by Dafinger, C. in: JCI | PubMed | Google Scholar

Find articles by Bernd, A. in: JCI | PubMed | Google Scholar

Find articles by Zrenner, E. in: JCI | PubMed | Google Scholar

Find articles by Claustres, M. in: JCI | PubMed | Google Scholar

Find articles by Blanco, B. in: JCI | PubMed | Google Scholar

Find articles by Nürnberg, G. in: JCI | PubMed | Google Scholar

Find articles by Nürnberg, P. in: JCI | PubMed | Google Scholar

Find articles by Ruland, R. in: JCI | PubMed | Google Scholar

Find articles by Westerfield, M. in: JCI | PubMed | Google Scholar

Find articles by Benzing, T. in: JCI | PubMed | Google Scholar

Find articles by Bolz, H. in: JCI | PubMed | Google Scholar

Published February 1, 2011 - More info

Published in Volume 121, Issue 2 on February 1, 2011
J Clin Invest. 2011;121(2):821–821. https://doi.org/10.1172/JCI46312.
© 2011 The American Society for Clinical Investigation
Published February 1, 2011 - Version history
View PDF

Related article:

PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome
Inga Ebermann, … , Thomas Benzing, Hanno J. Bolz
Inga Ebermann, … , Thomas Benzing, Hanno J. Bolz
Research Article Ophthalmology Article has an altmetric score of 1

PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome

  • Text
  • PDF
Abstract

Usher syndrome is a genetically heterogeneous recessive disease characterized by hearing loss and retinitis pigmentosa (RP). It frequently presents with unexplained, often intrafamilial, variability of the visual phenotype. Although 9 genes have been linked with Usher syndrome, many patients do not have mutations in any of these genes, suggesting that there are still unidentified genes involved in the syndrome. Here, we have determined that mutations in PDZ domain–containing 7 (PDZD7), which encodes a homolog of proteins mutated in Usher syndrome subtype 1C (USH1C) and USH2D, contribute to Usher syndrome. Mutations in PDZD7 were identified only in patients with mutations in other known Usher genes. In a set of sisters, each with a homozygous mutation in USH2A, a frame-shift mutation in PDZD7 was present in the sister with more severe RP and earlier disease onset. Further, heterozygous PDZD7 mutations were present in patients with truncating mutations in USH2A, G protein–coupled receptor 98 (GPR98; also known as USH2C), and an unidentified locus. We validated the human genotypes using zebrafish, and our findings were consistent with digenic inheritance of PDZD7 and GPR98, and with PDZD7 as a retinal disease modifier in patients with USH2A. Pdzd7 knockdown produced an Usher-like phenotype in zebrafish, exacerbated retinal cell death in combination with ush2a or gpr98, and reduced Gpr98 localization in the region of the photoreceptor connecting cilium. Our data challenge the view of Usher syndrome as a traditional Mendelian disorder and support the reclassification of Usher syndrome as an oligogenic disease.

Authors

Inga Ebermann, Jennifer B. Phillips, Max C. Liebau, Robert K. Koenekoop, Bernhard Schermer, Irma Lopez, Ellen Schäfer, Anne-Francoise Roux, Claudia Dafinger, Antje Bernd, Eberhart Zrenner, Mireille Claustres, Bernardo Blanco, Gudrun Nürnberg, Peter Nürnberg, Rebecca Ruland, Monte Westerfield, Thomas Benzing, Hanno J. Bolz

×

Original citation: J. Clin. Invest. 2010;120(6):1812–1823. doi:10.1172/JCI39715.

Citation for this clarification: J. Clin. Invest. 2011;121(2):821. doi:10.1172/JCI46312.

Since the article was published, the zebrafish genome assembly has been updated from zv8 to zv9, and the exon numbers have changed. The ush2a GT sequence (5′-GTACGACCTTATGCTTACCTGTTGG-3′) was originally thought to target the splice donor site of exon 6, but it has been updated to exon 4 of ush2a, as annotated in the Ensembl transcript ID ENSDART00000086201.

Version history
  • Version 1 (February 1, 2011): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
180 readers on Mendeley
See more details